Strategies to Maximize the Benefits of Evidence-Based Enteral Nutrition: A Narrative Review
- PMID: 40077715
- PMCID: PMC11901663
- DOI: 10.3390/nu17050845
Strategies to Maximize the Benefits of Evidence-Based Enteral Nutrition: A Narrative Review
Abstract
Enteral nutrition (EN) has been reported to have some physiological importance for critically ill patients. However, the advantage of EN over parenteral nutrition remains controversial in recent paradigms. To maximize the benefits and efficiency of EN, implementing measures based on comprehensive evidence is essential. Here, we systematically reviewed EN-related studies and integrated them into the best and most up-to-date EN practices. We extracted studies from 13 systematic reviews during the development of Japanese Critical Care Nutrition Guidelines, summarizing findings on the assessment of enteral feeding intolerance (EFI), the timing of EN, formula composition and nutrients, and method of administration in critically ill adult patients. Multifaceted EFI assessment may be needed in patients for high-risk patients. Early EN may reduce infectious complications, and initiating EN even earlier may offer an additional advantage. High protein intake (≥1.2 g/kg/day) could maintain muscle mass and physical function without increasing gastrointestinal complications. Probiotics, prebiotics, and synbiotics may serve as beneficial options for preventing infection and gastrointestinal complications, although their efficacy depends on the strains, types, and combinations used. For patients with EFI, post-pyloric feeding could be an effective approach, while intermittent feeding may be a safer approach. Both methods should be utilized to achieve nutritional targets. Integrating these nutritional interventions into EN strategies may help maximize their effectiveness and minimize complications. However, careful consideration regarding timing, dosage, nutrient selection, administration methods, and patient selection is required.
Keywords: enteral feeding intolerance; gastrointestinal complications; intensive care unit; nutritional therapy.
Conflict of interest statement
Author Hiroomi Tatsumi received an honorarium from Otsuka Pharmaceutical Co., Ltd. Author Hidenori Kasuya was employed by the Social Medical Corporation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Singer P., Reintam Blaser A., Berger M.M., Calder P.C., Casaer M., Hiesmayr M., Montejo-Gonzalez J.C., Pichard C., Preiser J.-C., van Zanten A.R.H., et al. ESPEN Practical and Partially Revised Guideline: Clinical Nutrition in the Intensive Care Unit. Clin. Nutr. 2023;42:1671–1689. doi: 10.1016/j.clnu.2023.07.011. - DOI - PubMed
-
- Compher C., Bingham A.L., McCall M., Patel J., Rice T.W., Braunschweig C., McKeever L. Guidelines for the Provision of Nutrition Support Therapy in the Adult Critically Ill Patient: The American Society for Parenteral and Enteral Nutrition. JPEN J. Parenter. Enter. Nutr. 2022;46:12–41. doi: 10.1002/jpen.2267. Corrigendum in JPEN 2022, 46, 1458–1459. https://doi.org/10.1002/jpen.2419 . - DOI - PubMed
-
- Reintam Blaser A., Starkopf J., Alhazzani W., Berger M.M., Casaer M.P., Deane A.M., Fruhwald S., Hiesmayr M., Ichai C., Jakob S.M., et al. Early Enteral Nutrition in Critically Ill Patients: ESICM Clinical Practice Guidelines. Intensive Care Med. 2017;43:380–398. doi: 10.1007/s00134-016-4665-0. - DOI - PMC - PubMed
-
- Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., Machado F.R., McIntyre L., Ostermann M., Prescott H.C., et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med. 2021;47:1181–1247. doi: 10.1007/s00134-021-06506-y. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
